Inés Urrutia

Inés Urrutia

Auto-generated profile, based on publicly available information

Inés Urrutia

Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2020 in Scientific Reports
Verified
Journal Article
Open access
Gemma Rojo-MartinezGemma Rojo-Martinez
Gemma Rojo-Martinez
SVSergio Valdés
Sergio Valdés
FSF. Soriguer
F. Soriguer
Vendrell JoanVendrell Joan
Vendrell Joan
IUI. Urrutia
I. Urrutia
ACAlfonso Calle-Pascual
Alfonso Calle-Pascual
Our aim was to determine the incidence of type 2 diabetes mellitus in a nation-wide population based cohort from Spain (di@bet.es study). The target was the Spanish population. In total 5072 people older than 18 years,were randomly selected from all over Spain). Socio-demographic and clinical data, survey on habits (physical activity and food consumption) and weight, height, waist, hip and blood pressure were recorder. A fasting blood draw and an oral glucose tolerance test were performed. Determinations of serum glucose were made. In the follow-up the same variables were collected and HbA1c was determined. A total of 2408 subjects participated in the follow-up. In total, 154 people developed diabetes (6.4% cumulative incidence in 7.5 years of follow-up). The incidence of diabetes adjusted for the structure of age and sex of the Spanish population was 11.6 cases/1000 person-years (IC95% = 11.1–12.1). The incidence of known diabetes was 3.7 cases/1000 person-years (IC95% = 2.8–4.6). The main risk factors for developing diabetes were the presence of prediabetes in cross-sectional study, age, male sex, obesity, central obesity, increase in weight, and family history of diabetes. This work provides data about population-based incidence rates of diabetes and associated risk factors in a nation-wide cohort of Spanish population.

1 February 2017 in Thyroid®
Verified
Journal Article
Closed access
SVSergio Valdés
Sergio Valdés
CMCristina Maldonado-Araque
Cristina Maldonado-Araque
ALAna M Lago-Sampedro
Ana M Lago-Sampedro
JLJ. Antonio Lillo
J. Antonio Lillo
EGEduardo Garcia-Fuentes
Eduardo Garcia-Fuentes
Gemma Rojo-MartinezGemma Rojo-Martinez
Gemma Rojo-Martinez
Background: The aim of this study was to investigate the national prevalence of thyroid dysfunction in Spain and its association with various clinical, environmental, and demographic variables. Methods: The study included 4554 subjects (42.4% men) with a mean age of 50 years (range 18–93 years), who were participants in a national, cross-sectional, population-based survey conducted in 2009–2010. Data gathered included clinical and demographic characteristics, physical examination, and blood sampling. Thyrotropin, free thyroxine, free triiodothyronine, and thyroid peroxidase antibody (TPOAb) concentrations were analyzed by electrochemiluminescence. Urinary iodine (UI) levels were measured in an isolated urine sample. Results: The prevalence of treated hypothyroidism, untreated subclinical hypothyroidism, and untreated clinical hypothyroidism was 4.2% [confidence interval (CI) 3.6–4.9%], 4.6% [CI 4.0–5.2%], and 0.3% [CI 0.1–0.5%], respectively. The prevalence of total hypothyroidism (including all fractions) was 9.1% [CI 8.2–10.0%]. The prevalence of total hyperthyroidism was 0.8% [CI 0.6–1.1]. A total of 7.5% [CI 6.7–8.3%] of the population tested positive for TPOAbs (≥50 IU/mL). In multivariate logistic regression models, TPOAbs were strongly associated with both hypothyroidism ( p < 0.001) and hyperthyroidism ( p = 0.005), whereas high UI levels (>200 μg/g creatinine) were associated with hypothyroidism ( p < 0.001). The positive association between UI and hypothyroidism remained for both treated ( p < 0.001) and untreated ( p < 0.05) hypothyroidism, whereas it was especially significant for non-autoimmune (TPOAbs negative) forms ( p < 0.001). At UI levels ≥200 μg/g, there was a positive correlation between UI and thyrotropin levels (β = 0.152, p < 0.001) and a negative correlation between UI and free triiodothyronine levels (β = −0.134, p = 0.001). Conclusion: According to the data, a large proportion (10%) of the Spanish population has some evidence of thyroid dysfunction. High TPOAb concentrations were associated with both hypo- and hyperthyroidism, whereas high UI concentrations were associated with hypothyroidism.

1 June 2016 in Revista Española de Cardiología (English Edition)
Verified
Journal Article
Closed access
ETEdelmiro Menéndez Torre
Edelmiro Menéndez Torre
Elias DelgadoElias Delgado
Elias Delgado
FFFrancisco Fernández-Vega
Francisco Fernández-Vega
MPMiguel A. Prieto
Miguel A. Prieto
EBElena Bordiú
Elena Bordiú
FSFederico Soriguer
Federico Soriguer

9 March 2017 in Obesity
Verified
Journal Article
Open access
PDF file
SVSergio Valdés
Sergio Valdés
CMCristina Maldonado-Araque
Cristina Maldonado-Araque
ALAna M Lago-Sampedro
Ana M Lago-Sampedro
JLJuan Antonio Lillo‐Muñoz
Juan Antonio Lillo‐Muñoz
EGEduardo Garcia-Fuentes
Eduardo Garcia-Fuentes
Gemma Rojo-MartinezGemma Rojo-Martinez
Gemma Rojo-Martinez
Objective: To analyze the reference range of thyroid‐stimulating hormone (TSH) in different BMI categories and its impact on the classification of hypothyroidism.Methods: The study included 3,928 individuals free of thyroid disease (without previous thyroid disease, no interfering medications, TSH <10 µUI/mL and thyroid peroxidase antibodies [TPO Abs] <50 IU/mL) who participated in a national, cross‐sectional, population‐based study and were representative of the adult population of Spain. Data gathered included clinical and demographic characteristics, physical examination, and blood and urine sampling. TSH, free thyroxine, free triiodothyronine, and TPO Ab were analyzed by electrochemiluminescence (E170, Roche Diagnostics, Basel, Switzerland).Results: The reference range (p2.5‐97.5) for TSH was estimated as 0.6 to 4.8 µUI/mL in the underweight category (BMI<20 kg/m2), 0.6 to 5.5 µUI/mL in the normal‐weight category (BMI 20‐24.9 kg/m2), 0.6 to 5.5 µUI/mL in the overweight category (BMI 25‐29.9 kg/m2), 0.5 to 5.9 µUI/mL in the obesity category (BMI 30‐39.9 kg/m2), and 0.7 to 7.5 µUI/mL in the morbid obesity category (BMI ≥40). By using the reference criteria for the normal‐weight population, the prevalence of high TSH levels increased threefold in the morbid obesity category (P < 0.01).Conclusions: Persons with morbid obesity might be inappropriately classified if the standard ranges of normality of TSH for the normal‐weight population are applied to them.

13 August 2014 in Obesity
Verified
Journal Article
Open access
PDF file
SVSergio Valdés
Sergio Valdés
CMCristina Maldonado-Araque
Cristina Maldonado-Araque
FGFrancisca García-Torres
Francisca García-Torres
AGAlberto Goday
Alberto Goday
ABAna Bosch-Comas
Ana Bosch-Comas
Gemma Rojo-MartinezGemma Rojo-Martinez
Gemma Rojo-Martinez
Objective The aim of this study was to examine possible associations between ambient temperature and obesity in the Spanish population using an ecological focus. Methods The Di@bet.es study is a national, cross‐sectional, population‐based survey of cardiometabolic risk factors and their association with lifestyle. Sample: 5,061 subjects in 100 clusters. Variables: Clinical, demographic and lifestyle survey, physical examination, and blood sampling. The mean annual temperature (°C) for each study site was collected from the Spanish National Meteorology Agency (1971‐2000). Results The prevalence rates of obesity in the different geographical areas divided according to mean annual temperature quartiles were 26.9% in quartile 1 (10.4‐14.5°C), 30.5% in quartile 2 (14.5‐15.5°C), 32% in quartile 3 (15.5‐17.8°C), and 33.6% in quartile 4 (17.8‐21.3°C) (P = 0.003). Logistic regression analyses including multiple socio‐demographic (age, gender, educational level, marital status) and lifestyle (physical activity, Mediterranean diet score, smoking) variables showed that, as compared with quartile 1, the odd ratios for obesity were 1.20 (1.01‐1.42), 1.35 (1.12‐1.61), and 1.38 (1.14‐1.67) in quartiles 2, 3, and 4, respectively (P = 0.001 for difference, P < 0.001 for trend). Conclusions Our study reports an association between ambient temperature and obesity in the Spanish population controlled for known confounders.

10 January 2017 in Diabetes
Verified
Journal Article
Open access
PDF file
TVTeresa Velayos
Teresa Velayos
RMRosa Martínez
Rosa Martínez
MAMilagros Alonso
Milagros Alonso
KGKoldo Garcia-Etxebarria
Koldo Garcia-Etxebarria
AAAnibal Aguayo
Anibal Aguayo
LCLuis Castaño
Luis Castaño
Neonatal diabetes mellitus (NDM) is a rare form of diabetes diagnosed within the first 6 months of life. Genetic studies have allowed the identification of several genes linked to the development of NDM; however, genetic causes for ∼20% of the cases remain to be clarified. Most cases of NDM involve isolated diabetes, but sometimes NDM appears in association with other pathological conditions, including autoimmune diseases. Recent reports have linked activating mutations in STAT3 with early-onset autoimmune disorders that include diabetes of autoimmune origin, but the functional impact of STAT3-activating mutations have not been characterized at the pancreatic β-cell level. By using whole-exome sequencing, we identified a novel missense mutation in the binding domain of the STAT3 protein in a patient with NDM. The functional analyses showed that the mutation results in an aberrant activation of STAT3, leading to deleterious downstream effects in pancreatic β-cells. The identified mutation leads to hyperinhibition of the transcription factor Isl-1 and, consequently, to a decrease in insulin expression. These findings represent the first functional indication of a direct link between an NDM-linked activating mutation in STAT3 and pancreatic β-cell dysfunction.